AVECTAS
Avectas is a cell engineering technology company, enabling drug developers to manufacture potent engineered cell therapies at therapeutic volumes, with high efficiency and with minimal cell disruption. Avectas technology delivers advanced molecules such as mRNA, proteins and gene editing tools to a range of cell types including T cells for immuno-oncology applications. Unlike the current industry standard of vector-free delivery methods, cells engineered with Avectas technology require no recovery time, leading to a shorter, simpler, more cost effective process.
AVECTAS
Industry:
Biotechnology Health Care Medical
Founded:
2010-01-01
Address:
Maynooth, Kildare, Ireland
Country:
Ireland
Website Url:
http://www.avectas.com
Total Employee:
11+
Status:
Active
Total Funding:
38.87 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Similar Organizations
Healx
Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.
Current Employees Featured
Founder
Investors List
Disruptive Technologies Innovation Fund
Disruptive Technologies Innovation Fund investment in Grant - Avectas
Seamus Mulligan
Seamus Mulligan investment in Series C - Avectas
Seamus Mulligan
Seamus Mulligan investment in Venture Round - Avectas
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Avectas
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-02 | Avectas Announces New Chief Technology Officer |
Official Site Inspections
http://www.avectas.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
